OLUKOTUN ADEOYE Y Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$5,029.00
Insider Sells Quantity
5
Insider Sells Sum
$1.03M

Insider Activity of OLUKOTUN ADEOYE Y

According to the SEC Form 4 filings, OLUKOTUN ADEOYE Y, being in a position of

  1. director at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12000 shares for $850,543,
    over all time since 2021-09-13, has bought 0 shares, and sold 36209 shares for $1.88M.

Biography of OLUKOTUN ADEOYE Y

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $850,5432100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
2,000
0.0014%
$86.96$173,920-25.08%
2025-12-19SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
10,000
0.0072%
$67.66$676,623+2.66%
2025-01-23SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
959
0.0007%
$21.00$20,139-7.66%
2024-12-27SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
2,850
0.0024%
$20.00$57,000-0.16%
2023-03-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
11,350
0.0107%
$32.65$370,578-7.39%
2022-01-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
4,050
0.0036%
$64.75$262,233-43.25%
2021-09-13SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
5,000
0.0048%
$63.76$318,800-27.31%
2020-08-13PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
director
5,350
<0.0001%
$0.94$5,029-14.11%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.